TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31225537

Group type: EXPERIMENTAL
Intervention: Molar-Incisor Hypomineralisation (MIH)
Number of subjects: 779

Group type: EXPERIMENTAL
Intervention: Caries
Number of subjects: 779

Group type: EXPERIMENTAL
Intervention: Fluorosis
Number of subjects: 779
Study: 28056202

Group type: EXPERIMENTAL
Intervention: T-DM1
Number of subjects: 1095

Group type: EXPERIMENTAL
Intervention: T-DM1 plus pertuzumab
Number of subjects: 1095

Group type: COMPARATOR
Intervention: Trastuzumab plus taxane
Number of subjects: 1095
Study: 24955752

Group type: EXPERIMENTAL
Intervention: Lurasidone (40-160 mg/d)
Number of subjects: 1330

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1330
Study: 23211552

Group type: EXPERIMENTAL
Intervention: Gadobutrol (1.0 M)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Gadobenate dimeglumine (0.5 M)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Gadoterate meglumine (0.5 M)
Number of subjects: 20
Study: 21262858

Group type: EXPERIMENTAL
Intervention: donepezil 5 mg
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: donepezil 7.5 mg
Number of subjects: 42

Group type: COMPARATOR
Intervention: glucose (placebo)
Number of subjects: 42
Study: 19876544

Group type: EXPERIMENTAL
Intervention: Cluster randomized controlled trials (RCTs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 0
Study: 16970163

Group type: EXPERIMENTAL
Intervention: Comprehensive behaviour psychotherapy + medicine therapy
Number of subjects: 90

Group type: COMPARATOR
Intervention: Medicine therapy
Number of subjects: 90
Study: 15540688

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IPC) in FDB group
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IPC) in ABF group
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (AAA)
Number of subjects: 17
Study: 11583866

Group type: EXPERIMENTAL
Intervention: Early invasive management strategy
Number of subjects: 1473

Group type: COMPARATOR
Intervention: Early conservative (medical) management strategy
Number of subjects: 1473
Study: 9422950

Group type: EXPERIMENTAL
Intervention: Co-amoxiclav (Augmentin)
Number of subjects: 250

Group type: COMPARATOR
Intervention: No antibiotics
Number of subjects: 250
Study: 7839518

Group type: EXPERIMENTAL
Intervention: Vitaria oxygen delivery system (75 mg sodium carbonate powder, max flow of 1 l/min for 15 minutes)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (no oxygen responses)
Number of subjects: 20
Study: 3147338

Group type: EXPERIMENTAL
Intervention: Topical application of nitroglycerin to the gum (trinitrolong, TNL)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Topical application of nitroglycerin to the skin (nitroderm, ND)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Topical application of nitroglycerin (both TNL and ND)
Number of subjects: 8
Study: 29558931

Group type: EXPERIMENTAL
Intervention: High intensity intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Medium intensity intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low intensity intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual implementation support
Number of subjects: 0

Group type: COMPARATOR
Intervention: High vs Medium intensity interventions
Number of subjects: 0
Study: 27113595

Group type: EXPERIMENTAL
Intervention: Kinematic Alignment (KA)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Mechanical Alignment (MA)
Number of subjects: 95
Study: 25563522

Group type: EXPERIMENTAL
Intervention: Eradication treatment
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Bronchoalveolar lavage (BAL) cultures
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Oropharyngeal cultures
Number of subjects: 168
Study: 23110884

Group type: EXPERIMENTAL
Intervention: 15mg of tiagabine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 21979185

Group type: EXPERIMENTAL
Intervention: Dynamic anorectal endosonography
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Dynamic MRI defecography
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional defecography
Number of subjects: 56
Study: 18445674

Group type: COMPARATOR
Intervention: Vitamin D3 at 14,000 IU/wk for 8 weeks (short-term study)
Number of subjects: 365

Group type: COMPARATOR
Intervention: Vitamin D3 at 1,400 IU/wk for 1 year (long-term study)
Number of subjects: 365

Group type: COMPARATOR
Intervention: Vitamin D3 at 14,000 IU/wk for 1 year (long-term study)
Number of subjects: 365

Group type: COMPARATOR
Intervention: Placebo (short-term and long-term studies)
Number of subjects: 365
Study: 17135177

Group type: EXPERIMENTAL
Intervention: Web-Based Training (WBT) module
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Face-to-face training workshop
Number of subjects: 166

Group type: COMPARATOR
Intervention: Delayed training control condition
Number of subjects: 166
Study: 12880458

Group type: EXPERIMENTAL
Intervention: Computer-assisted retinal vessel measurement for right eye
Number of subjects: 1546

Group type: EXPERIMENTAL
Intervention: Computer-assisted retinal vessel measurement for left eye
Number of subjects: 1546

Group type: EXPERIMENTAL
Intervention: Arteriole-to-venule ratio assessment
Number of subjects: 1546
Study: 10795116

Group type: EXPERIMENTAL
Intervention: Paroxetine (20-40 mg)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Amitriptyline (75-150 mg)
Number of subjects: 179
Study: 8623999

Group type: EXPERIMENTAL
Intervention: Parental presence during induction of anesthesia
Number of subjects: 84
Study: 1601756

Group type: EXPERIMENTAL
Intervention: Cefpirome 2 g intravenously
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 6527751

Group type: EXPERIMENTAL
Intervention: 80 mg of liquid haloperidol daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: 16 mg of liquid haloperidol daily
Number of subjects: 40
Study: 31399794

Group type: EXPERIMENTAL
Intervention: Custom-Made Skills Simulator (CMSS)
Number of subjects: 64

Group type: COMPARATOR
Intervention: da Vinci Skills Simulator (DVSS)
Number of subjects: 64
Study: 29293874

Group type: EXPERIMENTAL
Intervention: S-1 and irinotecan plus bevacizumab (experimental group)
Number of subjects: 487

Group type: COMPARATOR
Intervention: mFOLFOX6 or CapeOX plus bevacizumab (control group)
Number of subjects: 487
Study: 27336840

Group type: EXPERIMENTAL
Intervention: Balloon Kyphoplasty (BK)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Radiofrequency Kyphoplasty (RFK)
Number of subjects: 100
Study: 24891317

Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg/week
Number of subjects: 215

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 215

Group type: COMPARATOR
Intervention: Placebo switched to Etanercept at week 12
Number of subjects: 215
Study: 21970137

Group type: EXPERIMENTAL
Intervention: Midazolam 0.05 mg/kg (group M)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Propofol 1 mg/kg (group P)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Saline (group S)
Number of subjects: 101
Study: 19706558

Group type: EXPERIMENTAL
Intervention: 0.9% spinosad creme rinse without nit-combing
Number of subjects: 1038

Group type: COMPARATOR
Intervention: 1% permethrin with combing
Number of subjects: 1038

Group type: EXPERIMENTAL
Intervention: Both medications
Number of subjects: 1038
Study: 16916538

Group type: EXPERIMENTAL
Intervention: 60 mg MPH
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 90 mg MPH
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 20 mg cocaine
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 40 mg cocaine
Number of subjects: 7
Study: 14687240

Group type: EXPERIMENTAL
Intervention: 5-year diet intervention (traditional lipid-lowering diet with emphasis on reduction of saturated fat, total caloric intake and body weight)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 104
Study: 11417034

Group type: EXPERIMENTAL
Intervention: Prepackaged antimalarial drugs
Number of subjects: 0
Study: 9286191

Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 8103144

Group type: EXPERIMENTAL
Intervention: Laparoscopic appendicectomy (LA)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Open appendicectomy (OA)
Number of subjects: 140
Study: 3526085

Group type: EXPERIMENTAL
Intervention: Tamoxifen (10 mg orally bid)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 10
Study: 1090132

Group type: EXPERIMENTAL
Intervention: Bendroflumethiazide, 5 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Bendroflumethiazide, 5 mg plus Bumetanide, 4 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Bumetanide, 4 mg
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Bendroflumethiazide, 5 mg plus Spironolactone, 100 mg
Number of subjects: 18
Study: 31033612

Group type: EXPERIMENTAL
Intervention: Corrective exercises 3 times per week for 8 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 40
Study: 29016995

Group type: EXPERIMENTAL
Intervention: Mindfulness instruction (11 minutes)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Relaxation (active control)
Number of subjects: 68
Study: 26083408

Group type: EXPERIMENTAL
Intervention: Ensite NavX mapping-guided ablation
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional fluoroscopic mapping-guided ablation
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 64
Study: 23816410

Group type: EXPERIMENTAL
Intervention: Anti-tuberculous therapy for 8 months
Number of subjects: 365
Study: 21750555

Group type: COMPARATOR
Intervention: Dacarbazine + placebo
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Dacarbazine + 10 mg/kg intetumumab
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: 10 mg/kg intetumumab
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: 5 mg/kg intetumumab
Number of subjects: 129
Study: 19434235

Group type: EXPERIMENTAL
Intervention: BmrhGM-CSF (8 microg/kg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: rhGM-CSF (3.75 microg/kg)
Number of subjects: 19
Study: 17255151

Group type: EXPERIMENTAL
Intervention: Self-help group attendance (N = 50)
Number of subjects: 78

Group type: COMPARATOR
Intervention: No support (Control group, N = 28)
Number of subjects: 78
Study: 15023154

Group type: EXPERIMENTAL
Intervention: Valganciclovir 900 mg once daily
Number of subjects: 364

Group type: COMPARATOR
Intervention: Oral ganciclovir 1000 mg three times a day
Number of subjects: 364
Study: 11713941

Group type: EXPERIMENTAL
Intervention: High-dose interferon administered daily
Number of subjects: 77

Group type: COMPARATOR
Intervention: High-dose interferon administered three times weekly
Number of subjects: 77
Study: 9236422

Group type: EXPERIMENTAL
Intervention: Rotational Atherectomy
Number of subjects: 685

Group type: EXPERIMENTAL
Intervention: Excimer Laser Angioplasty
Number of subjects: 685

Group type: COMPARATOR
Intervention: Balloon Angioplasty
Number of subjects: 685
Study: 8213711

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid 1000 mg/day
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 3305443

Group type: EXPERIMENTAL
Intervention: Intrathecal methotrexate (IT MTX) only
Number of subjects: 504

Group type: COMPARATOR
Intervention: Cranial radiation and intrathecal methotrexate (IT MTX)
Number of subjects: 504
Study: 30016902

Group type: COMPARATOR
Intervention: Standard dose dexamethasone (9.9 mg IV on day 1 and 6.6 mg IV on days 2-4)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Low-dose dexamethasone (3.3 mg IV on days 1-4)
Number of subjects: 22
Study: 27353269

Group type: EXPERIMENTAL
Intervention: Patient-reported dosing information (PRDI)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Electronic monitoring-based adherence data
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: PRDI with a steady-state assumption
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Electronic monitoring records
Number of subjects: 404
Study: 25810849

Group type: EXPERIMENTAL
Intervention: Lidocaine 2% with epinephrine 1:80,000
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Prilocaine 3% with Felypressin 0.03 IU/ml
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Mepivacaine 3% plain
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 45
Study: 23631683

Group type: EXPERIMENTAL
Intervention: Jamie Oliver Ministry of Food Program (JMoF) Australia
Number of subjects: 250

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 250
Study: 20941843

Group type: EXPERIMENTAL
Intervention: Personalized physiotherapy program (n=150)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Usual physiotherapy program (n=74)
Number of subjects: 224
Study: 17945539

Group type: EXPERIMENTAL
Intervention: Zonisamide (ZNS) monotherapy, 100, 200, 300, and 400mg/day
Number of subjects: 43
Study: 16753240

Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV (Types 6/11/16/18) L1 virus‐like particle (VLP) vaccine
Number of subjects: 1106

Group type: COMPARATOR
Intervention: Placebo formulations
Number of subjects: 1106
Study: 15483207

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 1079
Study: 11454885

Group type: EXPERIMENTAL
Intervention: Tamoxifen (868 women)
Number of subjects: 1716

Group type: COMPARATOR
Intervention: Observation (848 women)
Number of subjects: 1716
Study: 9294907

Group type: EXPERIMENTAL
Intervention: Calcium alginate dressings
Number of subjects: 51

Group type: COMPARATOR
Intervention: Paraffin gauze dressings
Number of subjects: 51
Study: 7921311

Group type: EXPERIMENTAL
Intervention: Worksite-based nutrition intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 2870277

Group type: EXPERIMENTAL
Intervention: Different treatments received by the first 130 patients
Number of subjects: 272

Group type: COMPARATOR
Intervention: Different treatments received by the second group of 142 patients
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Patients who achieved complete remission
Number of subjects: 272
Study: 31608934

Group type: EXPERIMENTAL
Intervention: GLP-1 (1 pmol/kg/min)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: GIP (2 pmol/kg/min)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 12
Study: 29064141

Group type: COMPARATOR
Intervention: Dietetic advice and standard diet sheets
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Dietetic advice, diet sheets and use of the smart phone app
Number of subjects: 25
Study: 27121277

Group type: EXPERIMENTAL
Intervention: Coping With Strain (CWS) course
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control group (Intervention Group II - IG2)
Number of subjects: 119
Study: 24942170

Group type: EXPERIMENTAL
Intervention: 12-week strength training program (TG)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard physical conditioning program (CG)
Number of subjects: 12
Study: 22782386

Group type: EXPERIMENTAL
Intervention: Combined training (strength and endurance)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 204

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 204
Study: 20083627

Group type: EXPERIMENTAL
Intervention: High-dose losartan (150 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iron supplementation therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous-flow left ventricular assist devices
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atrial synchronized right ventricular pacing
Number of subjects: 0
Study: 19260630

Group type: EXPERIMENTAL
Intervention: Group C: 20 ml R0, 25% preincisional parietal and 20 ml R0, 25% intraperitoneal
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group A: 20 ml normal saline preincisional infiltration and 20 ml R0, 25% intraperitoneal
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Group B: 20 ml R0, 0.25% preincisional parietal and 20 ml normal saline intraperitoneal
Number of subjects: 60

Group type: COMPARATOR
Intervention: Group D: 20 ml normal saline preincisional local and 20 ml normal saline intraperitoneal
Number of subjects: 60
Study: 16899528

Group type: EXPERIMENTAL
Intervention: Selective laser trabeculoplasty (SLT)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Argon laser trabeculoplasty (ALT)
Number of subjects: 152
Study: 12543742

Group type: EXPERIMENTAL
Intervention: Lignocaine 2% gel
Number of subjects: 57

Group type: COMPARATOR
Intervention: Lignocaine 2% injection
Number of subjects: 57
Study: 10389775

Group type: EXPERIMENTAL
Intervention: Clonidine 3 microg/kg and famotidine 20 mg orally with propofol anesthesia
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Clonidine 3 microg/kg and famotidine 20 mg orally with isoflurane anesthesia
Number of subjects: 40

Group type: COMPARATOR
Intervention: No clonidine premedication with propofol anesthesia
Number of subjects: 40

Group type: COMPARATOR
Intervention: No clonidine premedication with isoflurane anesthesia
Number of subjects: 40
Study: 8537982

Group type: EXPERIMENTAL
Intervention: High-dose wheat bran fiber (13.5 g/day)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: High-dose calcium carbonate (1500 mg/day)
Number of subjects: 95
Study: 1795672

Group type: EXPERIMENTAL
Intervention: Exposure to vanadium pentoxide
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (not exposed to vanadium)
Number of subjects: 11
Study: 6337357

Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 100
Study: 31683326

Group type: EXPERIMENTAL
Intervention: Incubators covered for 24 hours (Group 1)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Incubators open for 24 hours (Group 2)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Incubators covered for 12 hours and open for 12 hours (Group 3)
Number of subjects: 32
Study: 31084966

Group type: EXPERIMENTAL
Intervention: Atrasentan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29183873

Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 27135476

Group type: EXPERIMENTAL
Intervention: Plyometric Training Program (PTP), biweekly for 8 weeks, including hurdle and drop jumps
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (C), standard soccer conditioning regimen
Number of subjects: 28
Study: 24529064

Group type: EXPERIMENTAL
Intervention: Iodine-125 thin seeds
Number of subjects: 18

Group type: COMPARATOR
Intervention: Standard I-125 stranded seeds
Number of subjects: 18
Study: 22207414

Group type: EXPERIMENTAL
Intervention: Acorn extract (2 g)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Galantamine (16 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 12
Study: 20422704

Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg daily for 5 days
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 17415689

Group type: EXPERIMENTAL
Intervention: Pulse synchronized pneumotonometry (PNT)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Routine pneumotonometry (PNT)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: PNT (both pulse synchronized and routine)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Goldmann applanation tonometry (GAT)
Number of subjects: 78
Study: 15791671

Group type: EXPERIMENTAL
Intervention: Blue light (405 nm) delivered at 40 J/cm2 to a 1-cm diameter spot in the gastric antrum
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control spots (not treated with blue light)
Number of subjects: 10
Study: 11791035

Group type: EXPERIMENTAL
Intervention: ACEI alone (fosinopril 20 mg/day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: ARB alone (irbesartan 150 mg/day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Combination of ACEI + ARB
Number of subjects: 10

Group type: COMPARATOR
Intervention: Baseline (without medication)
Number of subjects: 10
Study: 10457137

Group type: EXPERIMENTAL
Intervention: Sodium lauryl sulphate (SLS) challenges
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline surface hydration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single and iterative SLS challenges
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single water- or SLS-patch-tests
Number of subjects: 0
Study: 7781843

Group type: EXPERIMENTAL
Intervention: Nicotinamide (NA)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Nicotinamide (NA) + Cyclosporin (CyA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 2141274

Group type: EXPERIMENTAL
Intervention: Isotonic sodium chloride (2 litres)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ringer lactate solution (2 litres)
Number of subjects: 0
Study: 7470518

Group type: EXPERIMENTAL
Intervention: Feedback‐assisted HR lowering task (FG)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Unassisted HR lowering task (ICG)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Relaxation period (RCG)
Number of subjects: 27
Study: 31654268

Group type: EXPERIMENTAL
Intervention: Weight loss and lifestyle intervention
Number of subjects: 288
Study: 28600734

Group type: EXPERIMENTAL
Intervention: Varenicline (2 mg/day)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 25588767

Group type: EXPERIMENTAL
Intervention: Active rTMS (5 Hz, 3000 pulses per day for 10 days)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Sham rTMS (3000 pulses per day for 10 days)
Number of subjects: 4
Study: 24413845

Group type: EXPERIMENTAL
Intervention: Surgical treatment with an angular stable implant
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 50
Study: 22865576

Group type: EXPERIMENTAL
Intervention: Mupirocin sinonasal rinses (MUP)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Saline rinses (CON)
Number of subjects: 25